Kenvue /$KVUE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Kenvue
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Ticker
$KVUE
Sector
Primary listing
NYSE
Employees
21,890
Headquarters
Website
Kenvue Metrics
BasicAdvanced
$34bn
21.10
$0.84
-
$0.83
4.68%
Price and volume
Market cap
$34bn
52-week high
$25.17
52-week low
$14.02
Average daily volume
18m
Dividend rate
$0.83
Financial strength
Total debt to equity
80.576
Interest coverage (TTM)
6.97%
Profitability
EBITDA (TTM)
3,441.5
Gross margin (TTM)
58.61%
Net profit margin (TTM)
10.61%
Operating margin (TTM)
19.65%
Effective tax rate (TTM)
26.71%
Revenue per employee (TTM)
$700,000
Management effectiveness
Valuation
Price to earnings (TTM)
21.096
Price to revenue (TTM)
2.223
Price to book
3.15
Price to tangible book (TTM)
-4.56
Dividend yield (TTM)
4.67%
Forward dividend yield
4.68%
Growth
Revenue change (TTM)
-0.07%
Earnings per share change (TTM)
52.31%
3-year revenue growth (CAGR)
0.17%
3-year earnings per share growth (CAGR)
-10.26%
What the Analysts think about Kenvue
Analyst ratings (Buy, Hold, Sell) for Kenvue stock.
Kenvue Financial Performance
Revenues and expenses
Kenvue Earnings Performance
Company profitability
Kenvue News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Kenvue stock?
Kenvue (KVUE) has a market cap of $34B as of May 08, 2026.
What is the P/E ratio for Kenvue stock?
The price to earnings (P/E) ratio for Kenvue (KVUE) stock is 21.1 as of May 08, 2026.
Does Kenvue stock pay dividends?
Yes, the Kenvue (KVUE) stock pays dividends to shareholders. As of May 08, 2026, the dividend rate is $0.8275 and the yield is 4.68%. Kenvue has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Kenvue dividend payment date?
The next Kenvue (KVUE) dividend payment is scheduled for May 27, 2026.
What is the beta indicator for Kenvue ?
Kenvue (KVUE) does not currently have a Beta indicator.